Jeffrey Howard Lipton (Jeffrey H Lipton, Jeffrey Lipton)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Venues

European journal of haematology

Clinical drug investigation

American journal of hematology

EJHaem

Princess Margaret Cancer Centre

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Princess Margaret Cancer Centre

Canada

staff physician :: medical oncology and hematology

Publications

Jeffrey Howard Lipton
Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches. Clinical drug investigation 44 (2) (2024)
Jeffrey Howard Lipton
Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches. Clinical drug investigation (2024)
Jeffrey Howard Lipton
Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches. Clinical drug investigation 44 (2) (2024)
Jeffrey Howard Lipton
Imatinib versus newer generation TKIs for upfront therapy in chronic phase chronic myeloid leukemia: What is the rationale for paying more to get the same survival benefit? American journal of hematology (2024)
Ayman Sayyed, Leeann Wilson, Vered Stavi, Shiyi Chen, Carol Chen, Jonas Mattsson, Jeffrey Howard Lipton, Dennis Dong Hwan Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun Datt Law, Armin Gerbitz, Ivan Pasic, Igor Novitzky-Basso, Tony Mazzulli, Fotios V Michelis
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomes. European journal of haematology (2024)
Igor Novitzky-Basso, Wilson Lam, Caden Chiarello, Ivan Pasic, Arjun D Law, Fotios V Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Howard Lipton, Rajat Kumar, Jonas Mattsson, Hans A Messner, Theodore K Marras, Shikha Mittoo, Dennis Dong Hwan Kim
Prognostic implication of pre-transplant FEV 1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation. European journal of haematology (2023)
Tommy Alfaro Moya, Jonas Mattsson, Mats Remberger, Jeffrey Howard Lipton, Dennis Dong Hwan Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun Datt Law, Armin Gerbitz, Ivan Pasic, Igor Novitzky-Basso, Fotios V Michelis
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission. European journal of haematology (2023)
Vered Stavi, Nihar Desai, Fotios V Michelis, Dennis Dong Hwan Kim, Rajat Kumar, Jeffrey Howard Lipton, Arjun Datt Law
Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation after time-dependent discontinuation of prophylaxis. European journal of haematology (2023)
Ian Pang, Peggy Chen, Gertrude V Trinh, Mats Remberger, Igor Novitzky-Basso, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun D Law, Jeffrey Howard Lipton, Auro Viswabandya, Ivan Pasic, Jonas Mattsson, Fotios V Michelis
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data. European journal of haematology (2023)
Ram Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, Wilson Lam, Dawn Maze, Fotios V Michelis, Steven Chan, Vikas Gupta, Dennis Dong Hwan Kim, Rajat Kumar, Jeffrey Howard Lipton, Jonas Mattsson, Mark Minden, Aaron Schimmer, Hassan Sibai, Auro Viswabandya, Karen Yee, Tracy Murphy, Arjun D Law
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis. European journal of haematology (2023)
Ram Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, Wilson Lam, Dawn Maze, Fotios V Michelis, Steven Chan, Vikas Gupta, Dennis Dong Hwan Kim, Rajat Kumar, Jeffrey Howard Lipton, Jonas Mattsson, Mark Minden, Aaron Schimmer, Hassan Sibai, Auro Viswabandya, Karen Yee, Tracy Murphy, Arjun D Law
Mutational Profile, Outcomes, and Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia and Inconclusive Cytogenetic Analysis. European journal of haematology (2023)
Ram Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, Wilson Lam, Carol Chen, Fotios V Michelis, Dennis Dong Hwan Kim, Armin Gerbitz, Jeffrey Howard Lipton, Rajat Kumar, Jonas Mattsson, Auro Viswabandya
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma. European journal of haematology 108 (5) (2022)
Dennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, Seong Yoon Yi, Kyoung Ha Kim, Tracy Murphy, Steven Chan, Mark Minden, Ivan Pasic, Wilson Lam, Arjun Datt Law, Fotios V Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Howard Lipton, Rajat Kumar, Stanley W K Ng, Tracy Stockley, Tong Zhang, Ian King, Jonas Mattsson, Jean C Y Wang
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia. EJHaem 3 (3) (2022)
Igor Novitzky-Basso, Carol Chen, Shiyi Chen, Jeffrey Howard Lipton, Dennis D Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun Law, Zeyad Al-Shaibani, Armin Gerbitz, Ivan Pasic, Jonas Mattsson, Fotios V Michelis
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR. European journal of haematology 107 (3) (2021)
Igor Novitzky-Basso, Mats Remberger, Carol Chen, Cynthia Ellison, Ivan Pasic, Wilson Lam, Arjun Law, Armin Gerbitz, Auro Viswabandya, Jeffrey Howard Lipton, Dennis Dong Hwan Kim, Rajat Kumar, Fotios V Michelis, Jonas Mattsson
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors. European journal of haematology 108 (4) (2021)
Igor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, Ivan Pasic, Zeyad Al-Shaibani, Wilson Lam, Arjun Law, Fotios V Michelis, Armin Gerbitz, Auro Viswabandya, Jeffrey Howard Lipton, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes. European journal of haematology 106 (4) (2021)
Sunu L Cyriac, Shruti Prem, María Queralt Salas, Shiyi Chen, Zeyad Al-Shaibani, Wilson Lam, Arjun Law, Vikas Gupta, Fotios V Michelis, Dennis Dong Hwan Kim, Jeffrey Howard Lipton, Rajat Kumar, Jonas Mattsson, Auro Viswabandya
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis. European journal of haematology 107 (5) (2021)
Igor Novitzky-Basso, Mats Remberger, Carol Chen, Ivan Pasic, Wilson Lam, Arjun Law, Armin Gerbitz, Auro Viswabandya, Jeffrey Howard Lipton, Dennis D Kim, Rajat Kumar, Jonas Mattsson, Fotios V Michelis
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts. European journal of haematology 108 (1) (2021)
Rehab Alblooshi, Solaf Kanfar, Bridgette Lord, Eshetu G Atenafu, Fotios V Michelis, Ivan Pasic, Armin Gerbitz, Zeyad Al-Shaibani, Auro Viswabandya, Dennis Dong Hwan Kim, Wilson Lam, Arjun Law, Jonas Mattsson, Rajat Kumar, Jeffrey Howard Lipton
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant. European journal of haematology 106 (1) (2020)
María Queralt Salas, Shereen Ezzat, Wilson Lam, Arjun Datt Law, Ivan Pasic, Fotios V Michelis, Dennis Dong Hwan Kim, Armin Gerbitz, Zeyad Al-Shaibani, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Jeffrey Howard Lipton
Prolactin, a potential biomarker for chronic GVHD activity. European journal of haematology 106 (2) (2020)
Ayesh K Seneviratne, Clare Wright, Wilson Lam, Jeffrey Howard Lipton, Fotios V Michelis
Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation. European journal of haematology 106 (2) (2020)

Jeffrey Howard Lipton.css-eqlu8i{font-size:small;padding-left:4px;} (Jeffrey H Lipton, Jeffrey Lipton)

Publication Activity (10 Years)

Top Topics

Top Venues

Jeffrey Howard Lipton (Jeffrey H Lipton, Jeffrey Lipton)